DE60329115D1 - Tumorantigenprotein und dessen verwendung - Google Patents

Tumorantigenprotein und dessen verwendung

Info

Publication number
DE60329115D1
DE60329115D1 DE60329115T DE60329115T DE60329115D1 DE 60329115 D1 DE60329115 D1 DE 60329115D1 DE 60329115 T DE60329115 T DE 60329115T DE 60329115 T DE60329115 T DE 60329115T DE 60329115 D1 DE60329115 D1 DE 60329115D1
Authority
DE
Germany
Prior art keywords
tumorant
properties
protein
same
inducer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60329115T
Other languages
English (en)
Inventor
Noriyuki Sato
Tomohide Tsukahara
Yuki Nabeta
Satoshi Kawaguchi
Hideyuki Ikeda
Takuro Wada
Toshihiko Yamashita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Dainippon Pharma Co Ltd filed Critical Sumitomo Dainippon Pharma Co Ltd
Application granted granted Critical
Publication of DE60329115D1 publication Critical patent/DE60329115D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60329115T 2002-09-27 2003-09-19 Tumorantigenprotein und dessen verwendung Expired - Lifetime DE60329115D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002282345 2002-09-27
PCT/JP2003/012037 WO2004029248A1 (ja) 2002-09-27 2003-09-19 腫瘍抗原タンパク質及びその利用

Publications (1)

Publication Number Publication Date
DE60329115D1 true DE60329115D1 (de) 2009-10-15

Family

ID=32040535

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60329115T Expired - Lifetime DE60329115D1 (de) 2002-09-27 2003-09-19 Tumorantigenprotein und dessen verwendung

Country Status (7)

Country Link
US (2) US7700108B2 (de)
EP (1) EP1557466B1 (de)
JP (2) JP4484707B2 (de)
AT (1) ATE441713T1 (de)
AU (1) AU2003264535A1 (de)
DE (1) DE60329115D1 (de)
WO (1) WO2004029248A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE441713T1 (de) * 2002-09-27 2009-09-15 Dainippon Sumitomo Pharma Co Tumorantigenprotein und dessen verwendung
JP5606322B2 (ja) * 2008-10-20 2014-10-15 昇志 佐藤 腫瘍抗原ペプチド及びその利用
EP2966092A4 (de) * 2013-03-08 2016-11-16 Taiho Pharmaceutical Co Ltd Neuartiges peptid mit 5 verknüpften ctl-epitopen
JP6671956B2 (ja) * 2013-03-29 2020-03-25 大日本住友製薬株式会社 Ｅｒａｐ１によるトリミング機能をきっかけとしたコンジュゲートワクチン
WO2014157692A1 (ja) 2013-03-29 2014-10-02 大日本住友製薬株式会社 Ｗｔ１抗原ペプチドコンジュゲートワクチン
AU2014337643B2 (en) 2013-10-21 2017-07-13 Taiho Pharmaceutical Co., Ltd. Novel four-CTL epitope-joined peptide
WO2018101309A1 (ja) 2016-11-30 2018-06-07 大日本住友製薬株式会社 Ｗｔ１ヘルパーペプチド及びこれと癌抗原ペプチドコンジュゲート体との組合せ
TWI805792B (zh) 2018-06-29 2023-06-21 日商大鵬藥品工業股份有限公司 抗腫瘤劑及其評估方法
JPWO2024248120A1 (de) * 2023-05-31 2024-12-05

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083513A (en) * 1993-11-16 2000-07-04 Gerbu Biotechnik Gmbh Method for increasing the yield of antibodies in the techniques of immunology
JP3509199B2 (ja) 1994-06-15 2004-03-22 日本油脂株式会社 乳化剤組成物およびそれを用いた油中水型エマルシヨンの調製方法
JP3752711B2 (ja) 1995-11-02 2006-03-08 日本油脂株式会社 水中油中水型エマルシヨンの調製方法
JP2002513295A (ja) * 1997-07-08 2002-05-08 ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド １２３種類のヒト分泌タンパク質
KR100480546B1 (ko) * 1997-07-15 2005-04-06 다카라 바이오 가부시키가이샤 세포독성 티 림프구
KR20010086224A (ko) 1998-01-23 2001-09-10 추후제출 Ｍｅｔｈ1 및 ｍｅｔｈ2 폴리뉴클레오티드 및 폴리펩티드
US7071294B1 (en) 1998-12-01 2006-07-04 Green Peptide Co., Ltd. Tumor antigen protein art-1 and tumor antigen peptide thereof
US6635742B1 (en) * 2000-01-25 2003-10-21 Nuvelo, Inc. Antibodies specific for semaphorin-like polypeptides
AU2001264559A1 (en) * 2000-06-05 2001-12-17 Avalon Pharmaceuticals Cancer gene determination and therapeutic screening using signature gene sets
WO2002050103A2 (en) * 2000-12-20 2002-06-27 Glaxosmithkline Biologicals S.A. Tumour-related antigens
WO2002068579A2 (en) * 2001-01-10 2002-09-06 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
US7171311B2 (en) * 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
WO2003025136A2 (en) 2001-09-18 2003-03-27 Michigan Biotechnology Institute Method of enzyme production by microorganisms
ATE441713T1 (de) * 2002-09-27 2009-09-15 Dainippon Sumitomo Pharma Co Tumorantigenprotein und dessen verwendung

Also Published As

Publication number Publication date
EP1557466B1 (de) 2009-09-02
JP2010000083A (ja) 2010-01-07
US20100255579A1 (en) 2010-10-07
JPWO2004029248A1 (ja) 2006-01-26
US7700108B2 (en) 2010-04-20
US20080014636A1 (en) 2008-01-17
EP1557466A1 (de) 2005-07-27
AU2003264535A1 (en) 2004-04-19
EP1557466A4 (de) 2006-02-08
WO2004029248A1 (ja) 2004-04-08
JP5281515B2 (ja) 2013-09-04
JP4484707B2 (ja) 2010-06-16
ATE441713T1 (de) 2009-09-15

Similar Documents

Publication Publication Date Title
AU2001290837A1 (en) Use of a polypeptide comprising the extracellular domains of il-20rb for the treatment of inflammation
DE60235761D1 (de) Isoform des vegfs
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
ATE495247T1 (de) Chromoprotein und fluoroproteine
WO2006023665A3 (en) Il-1 antagonist formulations
WO2003048205A3 (fr) Proteines a activite inhibitrice de l'il-6
WO2002101052A3 (en) Salutaridinol 7-o-acetyltransferase and derivatives thereof
DE60228136D1 (de) Cytokin-proteinfamilie
ATE441713T1 (de) Tumorantigenprotein und dessen verwendung
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
EP0816504A3 (de) Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen
DE60229883D1 (de) Biologisch aktive peptide
DE60234843D1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
ATE521635T1 (de) Physiologisch wirksamer komplex mit tnf aktivität
WO2004000870A3 (en) Two synthetic peptides for treatment and prevention of cancers
AU2003202489A1 (en) Screening method
SG170757A1 (en) Polypeptide having esterase activity and recombinant esterase and use thereof
WO2004013167A3 (en) Purified polypeptides from enterococcus faecalis
WO2003018806A1 (fr) Nouveau gene humain bmcc1
ATE278784T1 (de) Polypeptide
WO2003027274A3 (en) Purified polypeptides from pseudomonas aeruginosa
ATE301199T1 (de) Beta-primeverosidase gen
ATE409747T1 (de) Mit wt1 interagierendes protein, wtip
WO2004042044A3 (en) Crystal structures of bacterial guanylate kinases
WO1999060117A3 (fr) Polypeptide prax-1

Legal Events

Date Code Title Description
8364 No opposition during term of opposition